Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.45% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
MGNX · Jun 30, 2026
MACROGENICS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001125345-26-000056General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-124.11% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
47.62% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-42.19% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
118.12% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
6.01% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20250/8 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 1.66%
- Current
- 2.45%
- Delta
- 0.80%
- Previous
- -172.38%
- Current
- -124.11%
- Delta
- 48.26%
- Previous
- 57.48%
- Current
- 47.62%
- Delta
- -9.86%
- Previous
- -160.96%
- Current
- -42.19%
- Delta
- 118.77%
- Previous
- 168.35%
- Current
- 118.12%
- Delta
- -50.23%
- Previous
- 12.74%
- Current
- 6.01%
- Delta
- -6.72%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · MACROGENICS INC →Transitioned To · MGNX Fundamental State →Transitioned To · MGNX CAPEX_INTENSITY_INCREASED →Transitioned To · MGNX CASH_GENERATION_INCREASED →Transitioned To · MGNX GROWTH_DECREASED →Transitioned To · MGNX PROFITABILITY_INCREASED →Transitioned To · MGNX R_AND_D_INTENSITY_DECREASED →Transitioned To · MGNX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.